Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Bolcato J"'
Autor:
Ingrasciotta, Y., Belleudi, V., Trotta, F., Addis, A., Fontana, A., Chinellato, A., Ientile, V., Tari, D. U., Roberto, G., Pastorello, M., Scondotto, S., Cananzi, P., Traversa, G., Davoli, M., Rossi, M., Trifiro, G., Caputi, A. P., Bolcato, J., Pirolo, R., Gini, R., Genazzani, A. A., Uomo, I., Addario, S. W. P., Da Cas, R.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 34(1)
Switching between different erythropoiesis-stimulating agents (ESAs) during the first year of therapy is frequent (15–20%), much more so toward reference products than biosimilars. The objectives of this study were to investigate the frequency and
Autor:
Belleudi, V., Trotta, F., Addis, A., Ingrasciotta, Y., Ientile, V., Tari, M., Gini, R., Pastorello, M., Scondotto, S., Cananzi, P., Traversa, G., Davoli, M., Trifiro, G., Caputi, A. P., Giorgianni, F., Marciano, I., Chinellato, A., Bolcato, J., Pirolo, R., Roberto, G., Genazzani, A. A., Uomo, I., Addario, S. W. P., Da Cas, R., Rossi, M.
Publikováno v:
Drug Safety
Introduction Real-world data on the comparative effectiveness and safety of switching among different epoetins (including originators and biosimilars) are limited. In light of current debate about interchangeability, prescribers, some patient groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf529b0f43166214bf600a2d5c7cf206
http://hdl.handle.net/11570/3168073
http://hdl.handle.net/11570/3168073
Publikováno v:
Giornale Italiano di Health Technology Assessment; 2013, Vol. 6 Issue 1, p49-54, 6p
Autor:
Deambrosis Paola, Bettiol Alessandra, Bolcato Jenny, Pirolo Roberta, Franchin Giulia, Themistoclakis Sakis, Pellizzari Michele, Chinellato Alessandro, Giusti Pietro
Publikováno v:
Acta Pharmaceutica, Vol 67, Iss 2, Pp 227-236 (2017)
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrilla
Externí odkaz:
https://doaj.org/article/c03be3ff7efc4d3cabe805c05c26b6a8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.